For healthier and more sustainably produced food
News
7/30/24 11:25 AM
Upcoming Webinar: Salt-tolerant endonucleases and the benefits for viral vector manufacturing, and a comparison of two marketed enzymes
Tuesday 27th August 202408:00 PDT / 11:00 EDT / 16:00 BST / 17:00 CEST Live30 webinars are thirty-minute presentations designed to update you on the.
read more
7/2/24 9:51 AM
Change in Management
Thomas Pfaadt will leave c-LEcta on 31 July 2024 and devote himself to a new professional challenge outside the company. On 1 June 2018, Thomas.
read more
Unique technology platform
c-LEcta uses its proprietary technology platform ENESYZ to develop customized enzymes and microbial production strains that meet the requirements of a wide range of manufacturing processes in industry. It has been continuously improved since its foundation in 2004 and has repeatedly proven its efficiency.
Why with c-LEcta?
For more than 400 customers worldwide, we are a reliable supplier of biotechnologically manufactured products that meet the highest quality requirements.